What is BioOrbit?
BioOrbit is at the forefront of revolutionizing healthcare delivery by specializing in innovative solutions that bring hospital-level care directly to patients' homes. The company harnesses advanced technology to enhance patient monitoring and treatment within a home setting, catering to individuals requiring continuous medical attention and healthcare providers aiming to improve patient outcomes. BioOrbit's core mission is to transform traditional healthcare paradigms by integrating cutting-edge, space-age technology into everyday patient care.
How much funding has BioOrbit raised?
BioOrbit has raised a total of $13.2M across 1 funding round:
Seed
$13.2M
Seed (2026): $13.2M with participation from Breega Capital, Type01, Auxxo Beteiligungen, and Seedcamp
Key Investors in BioOrbit
Breega Capital
Breega Capital is a venture capital firm specializing in backing exceptional founders from pre-Seed to Series A+ across Digital, Climate, and Deep Tech sectors, offering financial support and tactical insights.
Type01
TYPE01 aims to be a leading online type-focused design magazine, providing news and inspiration in type design, branding, and graphics, engaging design professionals and enthusiasts.
Auxxo Beteiligungen
Auxxo Female Catalyst Fund is a pre-seed and seed stage investment firm focused on supporting female co-founded startups across Europe, fostering a community of support and growth.
What's next for BioOrbit?
With the recent major strategic investment, BioOrbit is poised to accelerate its mission of transforming home-based healthcare. This capital infusion is expected to fuel further technological development, expand service offerings, and potentially broaden its market reach. The company's focus on leveraging advanced technology for patient monitoring and treatment in a home setting aligns with the growing trend towards decentralized healthcare, suggesting a strategic emphasis on scaling operations and enhancing patient accessibility.
See full BioOrbit company page
